JPMorgan lowered the firm’s price target on Badger Meter (BMI) to $160 from $190 and keeps an Overweight rating on the shares following a revenue and earnings miss in Q1. The miss was driven by a previously flagged project pacing dynamic and an “incremental, unexpected” softness in short-cycle order rates, but management was “emphatic” that neither reflects a structural change in underlying demand or competitive positioning, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMI:
